109 related articles for article (PubMed ID: 12478728)
1. Selective RXR modulators for the treatment of type II diabetes.
Faul MM; Grese TA
Curr Opin Drug Discov Devel; 2002 Nov; 5(6):974-85. PubMed ID: 12478728
[TBL] [Abstract][Full Text] [Related]
2. RAR and RXR modulation in cancer and metabolic disease.
Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
[TBL] [Abstract][Full Text] [Related]
3. Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes.
Michellys PY; Ardecky RJ; Chen JH; Crombie DL; Etgen GJ; Faul MM; Faulkner AL; Grese TA; Heyman RA; Karanewsky DS; Klausing K; Leibowitz MD; Liu S; Mais DA; Mapes CM; Marschke KB; Reifel-Miller A; Ogilvie KM; Rungta D; Thompson AW; Tyhonas JS; Boehm MF
J Med Chem; 2003 Jun; 46(13):2683-96. PubMed ID: 12801232
[TBL] [Abstract][Full Text] [Related]
4. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
de Lera AR; Bourguet W; Altucci L; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
[TBL] [Abstract][Full Text] [Related]
5. Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity.
Farooqui M; Franco PJ; Thompson J; Kagechika H; Chandraratna RA; Banaszak L; Wei LN
Biochemistry; 2003 Feb; 42(4):971-9. PubMed ID: 12549917
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in receptor-selective retinoids.
Nagpal S; Chandraratna RA
Curr Pharm Des; 2000 Jun; 6(9):919-31. PubMed ID: 10828316
[TBL] [Abstract][Full Text] [Related]
7. Syntheses and structure-activity relationships of novel retinoid X receptor agonists.
Hibi S; Kikuchi K; Yoshimura H; Nagai M; Tai K; Hida T
J Med Chem; 1998 Aug; 41(17):3245-52. PubMed ID: 9703470
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic applications for ligands of retinoid receptors.
Thacher SM; Vasudevan J; Chandraratna RA
Curr Pharm Des; 2000 Jan; 6(1):25-58. PubMed ID: 10637371
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acids.
Michellys PY; Ardecky RJ; Chen JH; D'Arrigo J; Grese TA; Karanewsky DS; Leibowitz MD; Liu S; Mais DA; Mapes CM; Montrose-Rafizadeh C; Ogilvie KM; Reifel-Miller A; Rungta D; Thompson AW; Tyhonas JS; Boehm MF
J Med Chem; 2003 Sep; 46(19):4087-103. PubMed ID: 12954061
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective synthesis and receptor activity of conformationally defined retinoid X receptor selective ligands.
Vuligonda V; Garst ME; Chandraratna RA
Bioorg Med Chem Lett; 1999 Feb; 9(4):589-94. PubMed ID: 10098670
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and structure-activity relationship of novel RXR-selective modulators.
Michellys PY; D'Arrigo J; Grese TA; Karanewsky DS; Leibowitz MD; Mais DA; Mapes CM; Reifel-Miller A; Rungta D; Boehm MF
Bioorg Med Chem Lett; 2004 Mar; 14(6):1593-8. PubMed ID: 15006411
[TBL] [Abstract][Full Text] [Related]
12. Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors.
García J; Khanwalkar H; Pereira R; Erb C; Voegel JJ; Collette P; Mauvais P; Bourguet W; Gronemeyer H; de Lera AR
Chembiochem; 2009 May; 10(7):1252-9. PubMed ID: 19343742
[TBL] [Abstract][Full Text] [Related]
13. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
Ahuja HS; Szanto A; Nagy L; Davies PJ
J Biol Regul Homeost Agents; 2003; 17(1):29-45. PubMed ID: 12757020
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes.
Yamauchi T; Waki H; Kamon J; Murakami K; Motojima K; Komeda K; Miki H; Kubota N; Terauchi Y; Tsuchida A; Tsuboyama-Kasaoka N; Yamauchi N; Ide T; Hori W; Kato S; Fukayama M; Akanuma Y; Ezaki O; Itai A; Nagai R; Kimura S; Tobe K; Kagechika H; Shudo K; Kadowaki T
J Clin Invest; 2001 Oct; 108(7):1001-13. PubMed ID: 11581301
[TBL] [Abstract][Full Text] [Related]
15. sp2-bridged diaryl retinoids: effects of bridge-region substitution on retinoid X receptor (RXR) selectivity.
Dawson MI; Hobbs PD; Jong L; Xiao D; Chao WR; Pan C; Zhang XK
Bioorg Med Chem Lett; 2000 Jun; 10(12):1307-10. PubMed ID: 10890152
[TBL] [Abstract][Full Text] [Related]
16. Determinants of retinoid X receptor transcriptional antagonism.
Cavasotto CN; Liu G; James SY; Hobbs PD; Peterson VJ; Bhattacharya AA; Kolluri SK; Zhang XK; Leid M; Abagyan R; Liddington RC; Dawson MI
J Med Chem; 2004 Aug; 47(18):4360-72. PubMed ID: 15317450
[TBL] [Abstract][Full Text] [Related]
17. Marked improvement induced in photoaged skin of hairless mouse by ER36009, a novel RARgamma-specific retinoid, but not by ER35794, an RXR-selective agonist.
Sakuta T; Kanayama T
Int J Dermatol; 2006 Nov; 45(11):1288-95. PubMed ID: 17076708
[TBL] [Abstract][Full Text] [Related]
18. DNA-looping by RXR tetramers permits transcriptional regulation "at a distance".
Yasmin R; Yeung KT; Chung RH; Gaczynska ME; Osmulski PA; Noy N
J Mol Biol; 2004 Oct; 343(2):327-38. PubMed ID: 15451664
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of fluorinated RXR modulators.
Gernert DL; Ajamie R; Ardecky RA; Bell MG; Leibowitz MD; Mais DA; Mapes CM; Michellys PY; Rungta D; Reifel-Miller A; Tyhonas JS; Yumibe N; Grese TA
Bioorg Med Chem Lett; 2003 Oct; 13(19):3191-5. PubMed ID: 12951091
[TBL] [Abstract][Full Text] [Related]
20. Treatment of non-insulin-dependent diabetes mellitus.
Patel M; Rybczynski PJ
Expert Opin Investig Drugs; 2003 Apr; 12(4):623-33. PubMed ID: 12665417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
